Cetrorelix Reference

Plain English

What it is

Cetrorelix (brand name Cetrotide) is a lab-made, protein-like medicine that is FDA-approved and given only by prescription. It works by blocking a hormone signal from the brain, which keeps the body from releasing an egg too early.

What people use it for

Fertility doctors use it during assisted reproduction such as in vitro fertilization (IVF). During an egg-growing cycle it holds back a sudden rise of a hormone called LH that could otherwise ruin the cycle. It is a clinic-managed fertility medicine, not something used for body composition.

What the science shows

Preventing an early LH surge during controlled ovarian stimulation is exactly the use it is FDA-approved for, and GnRH antagonists like it are a standard part of IVF care. The product label lists ovarian hyperstimulation syndrome, nausea, and headache as the most common side effects reported.

The catch

It is prescription-only and meant to be used inside a monitored fertility cycle run by clinicians experienced in fertility treatment. Use on your own is unsafe and outside FDA approval. Ovarian hyperstimulation syndrome (OHSS), a serious overreaction of the ovaries to the surrounding treatment, is a label-level concern.

Reference summary

Cetrorelix is a synthetic decapeptide GnRH antagonist that directly blocks pituitary GnRH receptors without the agonist flare phase. Unlike depot GnRH agonists, its effect comes on within hours and resolves within days after the last dose. The Cetrotide label is anchored to controlled ovarian stimulation in ART, where it prevents the premature LH surge that would otherwise cancel the cycle. Outside ART, cetrorelix has been studied in benign prostatic hyperplasia and hormone-sensitive disease, but there is no FDA-approved label for those uses.

Regulatory and posture

Categories

Reproductive, Hormonal

Aliases

Cetrotide, GnRH antagonist, Cetrorelix acetate

Evidence posture

human - Reproductive endocrinology drug. Prescription-only and prescribed in the context of a clinician-monitored ART cycle. Off-label or self-administered use is not safe and is outside FDA approval. Bone-density concerns of long GnRH-agonist use do not directly apply because cetrorelix is used short-term, but ovarian hyperstimulation syndrome (OHSS) is a label-level concern of the surrounding stimulation protocol.

Regulatory status

FDA-approved prescription medication (Cetrotide). Indicated to inhibit premature LH surges during controlled ovarian stimulation in assisted reproductive technology (ART) cycles. Prescription-only, written specifically for a single ART cycle, and dispensed through fertility programs.

Content review status

label verified

Related tools

• Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
• BAC water calculator - Solve BAC water volume for a target concentration.
• Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
• Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
• Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
• Injection-site rotation overview - Public overview of the Pro site-rotation planner.